title: Maximum urine concentrating ability in children with Hb SC disease: effects of hydroxyurea.
abstract: Studies in adults with Hb SC disease suggested that hydroxyurea reduced hemolysis and increased red cell hydration. Because increased hydration should diminish the polymerization tendency of Hb S we hypothesized that hydroxyurea might repair the urine concentration defect of HbSC disease. Eight Hb SC disease patients, aged 10 to 17 years, were given hydroxyurea daily. Maximal urine concentrating ability following overnight fasting and after subcutaneous arginine vasopressin (dDAVP), blood counts, and cell volumes were observed for 12-15 months. All patients had impaired urine concentrating ability prior to hydroxyurea treatment and failed to increase their ability to concentrate urine following treatment (maximum urine concentration after an overnight fast and dDAVP, 520-530 mOsm). Mean corpuscular volume (MCV) and reticulocyte MCV increased after administration of hydroxyurea, and the reticulocyte count and ratio of red cell hemoglobin to reticulocyte hemoglobin fell but there was little change in PCV. Hb F increased substantially in 2 patients but showed little change in the remaining patients. There was no evidence that hydroxyurea was associated with increased urine concentrating ability in children with Hb SC disease. These results may reflect irreversible renal medullary damage prior to beginning treatment or insufficient intensity or duration of treatment.
authors.affiliation: Department of Pediatrics, G. V. (Sonny) Montgomery VA Medical Center, Jackson, Mississippi 39216, USA.
authors.forename: R
authors.initials: R
authors.lastname: Iyer
authors.forename: R
authors.initials: R
authors.lastname: Baliga
authors.forename: R L
authors.initials: RL
authors.lastname: Nagel
authors.forename: C
authors.initials: C
authors.lastname: Brugnara
authors.forename: K
authors.initials: K
authors.lastname: Kirchner
authors.forename: S
authors.initials: S
authors.lastname: Hogan
authors.forename: M H
authors.initials: MH
authors.lastname: Steinberg
mesh_terms: D000293:Adolescent; D000328:Adult; D000986:Antisickling Agents / Q000008:administration & dosage*; D002648:Child; D005260:Female; D006450:Hemoglobin SC Disease / Q000188:drug therapy* / Q000503:physiopathology*; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage*; D007671:Kidney Concentrating Ability; D008297:Male
chemical_list: D000986:Antisickling Agents; D006918:Hydroxyurea